Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

2 Jul 2014 07:00

RNS Number : 1551L
Persimmon PLC
02 July 2014
 



 

TRADING UPDATE

 

WEDNESDAY 2 JULY 2014

 

 

Persimmon plc announces the following update ahead of its Half Year Results to 30 June 2014, which will be released on Tuesday 19 August 2014.

 

Trading during the first six months of this year has been strong. Total revenues have increased by 33% to £1.2 bn (2013 : £0.9bn). The Group legally completed 6,408 new homes (2013 : 5,022) during the period, up 28% on the prior year. Visitor numbers to our sites across the UK were 5% ahead and cancellation rates of 16% (2013 : 16%) have remained at low levels.

 

The Group's average selling price has increased by 4% to c.£186,000 (2013 : £179,199) primarily due to a continued increase in the proportion of larger family houses in the sales mix. Customer demand for good quality housing in attractive locations remains firm across all our regional markets.

 

Mortgage lenders have continued to support customer access to the housing market, exercising discipline in the improving market. This disciplined approach has been complemented by the implementation of the Mortgage Market Review and is further evidenced by recent adjustments to lending practices by major lenders. This has now been reinforced, with last week's announcement of measures by the Bank of England focussed on ensuring lending practices remain sustainable in the future.

 

As anticipated, we successfully opened 90 new sites in the first half of the year leaving our outlet network slightly lower at 380 active sites, having sold out a number of existing sites more swiftly due to stronger sales rates. We plan to open approximately 100 new sites during the second half of the year.

 

Our total forward sales revenue at 30 June 2014 of c.£1.18bn (2013 : £0.92bn) is 28% higher than last year. We have c.4,100 new homes sold forward into the private sale market which is 29% ahead year on year, with an average selling price of c.£204,600, 3% higher.

 

Our strong liquidity has supported substantial land replacement through the first six months with c.£290 million of land expenditure and c.14,300 new plots of land acquired. Our consented land bank at 30 June totals c.82,300 plots which provides an excellent platform for the future development of the business.

 

At 30 June 2014 cash holdings were c.£326 million (2013 : £48 million), resulting from c.£122 million (2013 : £75 million) of free cash net inflow in the first half of the year.

 

The second payment of our Capital Return Plan of c.£214 million, or 70p per share, is to be made on 4 July 2014 having received shareholders' approval at the Annual General Meeting on 16 April 2014.

 

With the gradual improvement in performance of the wider UK economy confidence in our regional markets across the UK remains positive as we enter the traditionally slower summer weeks. We will continue to focus on the successful delivery of our operational objectives and execution of our longer term strategy.

 

We will announce our Half Year Results on Tuesday 19 August 2014 and will provide further details at that time.

 

Please Note

 

There will be a call for analysts at 0900 BST today. Please use the dial-in details below:

 

Telephone number: +44 (0) 20 3003 2666

Conference code: Persimmon

 

An audiocast of the call will be available on www.corporate.persimmonhomes.com from this afternoon.

 

For further information, please contact:

 

Persimmon plc Citigate Dewe Rogerson

 

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

 

Tel: +44 (0)1904 642199 Tel: +44 (0)20 7638 9571

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGGNVMZGDZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.